Whole Cannabis May Work Better Than THC Alone for Cancer Wasting Because CBD Counteracts Psychoactive Side Effects
A review noted that cancer cachexia affects two-thirds of advanced patients and that whole cannabis may be better tolerated than THC alone because CBD and other cannabinoids reduce psychoactive effects without blocking appetite stimulation.
Quick Facts
What This Study Found
Anorexia and cachexia (severe weight loss) are diagnosed in more than two-thirds of cancer patients with advanced disease and independently increase illness and death risk. Patients often rate nausea and appetite loss as more detrimental to quality of life than even severe pain.
THC was licensed as an antiemetic in 1986 and had shown significant appetite stimulation and weight gain in clinical studies of HIV and cancer patients. However, the psychoactive side effects of pure THC limited its tolerability.
The review highlighted a key insight: whole cannabis appeared to be better tolerated than THC alone because it contains additional cannabinoids, particularly CBD, which counteract THC's psychoactive effects without inhibiting the appetite-stimulating effect. The authors proposed comparing whole-plant cannabis extracts to THC alone in controlled studies.
Key Numbers
More than two-thirds of advanced cancer patients develop cachexia. THC licensed as antiemetic in 1986. Appetite stimulation and weight gain demonstrated in HIV and cancer studies.
How They Did This
Narrative review of cancer cachexia literature and cannabinoid appetite stimulation research, proposing a research agenda for whole-plant extracts versus pure THC.
Why This Research Matters
This review articulated the "entourage effect" hypothesis in a clinical context: that whole cannabis containing multiple cannabinoids might have a better therapeutic profile than isolated THC. This concept drove the development of whole-plant cannabis medications.
The Bigger Picture
The hypothesis that whole cannabis outperforms isolated THC due to CBD modulation of psychoactive effects influenced the development of nabiximols (Sativex), which contains both THC and CBD. This whole-plant approach became a defining feature of modern cannabis therapeutics.
What This Study Doesn't Tell Us
The review presented a hypothesis for testing rather than established evidence. The "strong indications" that cannabis is better tolerated than THC alone were largely anecdotal at the time. The proposed controlled studies were not yet completed.
Questions This Raises
- ?Do controlled comparisons confirm that whole cannabis is better tolerated than THC alone?
- ?Which specific cannabinoids beyond CBD contribute to improved tolerability?
- ?Can the appetite-stimulating effect be maximized while minimizing psychoactive effects?
Trust & Context
- Key Stat:
- More than two-thirds of advanced cancer patients develop cachexia
- Evidence Grade:
- A narrative review proposing a research hypothesis. Provides rationale for whole-plant versus isolated cannabinoid comparison but not comparative evidence.
- Study Age:
- Published in 1999. Subsequent research has provided some support for the whole-plant approach, though evidence remains mixed.
- Original Title:
- Cancer cachexia and cannabinoids.
- Published In:
- Forschende Komplementarmedizin, 6 Suppl 3, 21-2 (1999)
- Authors:
- Gorter, R W(2)
- Database ID:
- RTHC-00080
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Is whole cannabis better than THC pills for appetite?
This review proposed it might be, because CBD and other cannabinoids in whole cannabis counteract THC's psychoactive side effects while preserving the appetite-stimulating effect. The hypothesis was proposed for controlled testing.
How common is cancer wasting?
Anorexia and cachexia affect more than two-thirds of advanced cancer patients and independently increase the risk of illness and death.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
- why-does-weed-make-you-hungry-munchies
- why-does-weed-make-food-taste-better
- cannabis-and-cancer-pain-beyond-chemo-nausea
Cite This Study
https://rethinkthc.com/research/RTHC-00080APA
Gorter, R W. (1999). Cancer cachexia and cannabinoids.. Forschende Komplementarmedizin, 6 Suppl 3, 21-2.
MLA
Gorter, R W. "Cancer cachexia and cannabinoids.." Forschende Komplementarmedizin, 1999.
RethinkTHC
RethinkTHC Research Database. "Cancer cachexia and cannabinoids." RTHC-00080. Retrieved from https://rethinkthc.com/research/gorter-1999-cancer-cachexia-and-cannabinoids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.